Return to PJ Online Home Page
The Pharmaceutical Journal Vol 265 No 7122 p711
November 11, 2000 Clinical

Pesticide link to Parkinson's disease?

Chronic exposure to substances like the pesticide rotenone may contribute to the development of Parkinson’s disease, say neurologists from the United States.
Dr Ranjita Betarbet and colleagues (department of neurology, Emory university, Atlanta, Georgia) gave rats continuous intravenous infusions of rotenone for up to five weeks.
The rats developed symptoms characteristic of Parkinson’s disease (PD), such as unsteady movement, rigidity and paw shake. They also developed lesions in the brain that resembled Lewy bodies, which are thought to be involved in triggering the death of dopaminergic neurones.
The results lend weight to the theory that environmental toxins ingested through diet or drinking water might contribute to the pathogenesis of PD, the authors say.
Dr Betarbet and colleagues say that rotenone is derived from plant roots and is used both as an insecticide in vegetable gardens and to kill fish. It is known to be a poison that inhibits mitochondrial respiration at complex I of the electron transport chain. Post mortem studies have shown that mitochondrial impairment and oxidative damage are “strongly implicated” in the pathogenesis of PD.
The severity of symptoms exhibited by the rats depended on the extent of the Lewy body-like lesions, and symptoms persisted even after the infusions of rotenone had been stopped (Nature Neuroscience 2000;3: 1301).
Commenting on the findings, Drs Benoit Giasson and Virginia Lee (centre for neurodegenerative disease research, University of Pennsylvania) say that the results are likely to raise questions about the safety of rotenone, although its contribution to the incidence of PD remains to be determined. “Although genetic factors certainly contribute to vulnerability, the most important risk factor for PD is age, consistent with the idea that chronic exposure to low levels of noxious substances over time may drive a molecular chain of events that eventually leads to PD,” they say (Nature Neuroscience 2000;3:1227).